Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

Here are Stifel’s best small and mid cap UK stocks for 2025

Investing.com — Stifel analysts highlighted their top small and mid-cap UK stock picks for 2025, focusing on sectors such as industrials, healthcare, and technology.

Industrials: AB Dynamics
AB Dynamics stands out as Stifel’s top small-cap pick in the industrials sector. The firm said the company is poised to triple its profit in the next 3-5 years due to its significant investments in operations and infrastructure.

Stifel notes the potential for “sharply rising margins and strong cash flow” driven by “rising globalising ADAS regulation” and ongoing M&A activities. The analysts believe that the company’s shares could more than double if medium-term goals are achieved.

Healthcare: Hikma Pharmaceuticals (OTC:HKMPY)
In healthcare, Hikma Pharmaceuticals is noted for its diversified operations across injectables, branded, and generics. The injectables segment, particularly in the US, contributes significantly to the company’s EBIT, while the branded division leads in the MENA region. Stifel highlights the company’s focus on complex generics and specialty products, predicting steady growth across its divisions.

Technology: Kainos
Kainos is Stifel’s top technology pick, benefiting from its positioning in government digital transformation and its strong partnership with Workday (NASDAQ:WDAY). The company’s focus on high-margin Workday products and a stable business model with good cash generation are seen as underpinning its growth prospects. Stifel anticipates a healthy backlog and further business wins, supported by the return of CEO Brendan Mooney.

Metals & Mining: Endeavour Mining
Endeavour Mining is highlighted for its diversified portfolio of low-cost, long-life mines in West Africa. Stifel expects strong free cash flow to reduce net debt and support shareholder returns. The company’s sector-leading margins and discovery costs make it an attractive investment for 2025.

Other names that made the list include Melrose (LON:MRON) due to its strong profitability and incoming inflection, Animalcare, based on its Randlab acquisition enhancing its growth prospects, and Persimmon (LON:PSN) as “housebuilders offer “compelling risk/reward here.”

Mondi (LON:MNDI), Restore, Kitwave, Future, Ashtead (LON:AHT) Tech, and Assura were other names highlighted by the firm.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com